Pain Management News

• Noninvasive Brain Stim a Breakthrough for Hypnotherapy? Brief TMS can boost an individual's hypnotizability, in new findings that may increase the efficacy of therapeutic hypnosis and expand the pool of patients benefiting from it.
  Medscape Medical News, January 08, 2024
  10
• Intensive Weight Loss Does Not Ease Gout Symptoms Researchers found an association between weight loss and a corresponding reduction in serum urate, but more weight loss did not result in positive changes in pain or fatigue.
  Medscape Medical News, January 08, 2024
  1
• Alert FDA Gives Nod to Berdazimer Gel for Molluscum Contagiosum The topical treatment is expected to be commercially available in the second half of 2024.
  Medscape Medical News, January 05, 2024
  1
• FDA Evaluating 3 Side Effects Reported for Weight Loss Drugs A new report listed potential links between GLP-1 agonists and alopecia, aspiration during surgery, and suicidal ideation.
  WebMD Health News, January 05, 2024
  24
• 'Left in the Dark': Prior Auth Erodes Trust, Costs More A surprising prior authorization requirement left an oncologist's patient in extreme pain over the weekend.
  Medscape Medical News, January 04, 2024
  46
• Higher-Dose Atypical Antipsychotics Risky in Young Adults Higher doses of a second-generation antipsychotic are associated with an increased risk of dying in young adults aged 18-24 years, results of a large retrospective cohort study showed.
  Medscape Medical News, January 04, 2024
• Why Do MDs Have Such a High Rate of Eating Disorders? Data suggested medical professionals may have eating disorders at twice the rate of the population — while few talk about it. Here's what to know.
  Medscape Medical News, January 04, 2024
  34
• Assessing Patients With AD: Tools to Use in the Office "It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC.
  MDedge News, January 04, 2024
• Experimental Topical Drug Shows Promise for AD, Psoriasis In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.
  MDedge News, January 04, 2024
  2
• Tips for Managing Axial Spondyloarthritis in Primary Care The rheumatology consultation may have been requested, but how can primary care practitioners help their patients who have suspected axial spondyloarthritis in the meantime?
  Medscape Medical News, January 03, 2024
  3
• Ascending Thoracic Aortic Aneurysms: A 'Silver Lining'? While they can be fatal upon rupture or dissection, ascending thoracic aortic aneurysms are also associated with apparent protection against atherosclerosis.
  Medscape Medical News, January 02, 2024
  7
• To-Go Buprenorphine: A Boon for Opioid Misuse Patients The process of refilling prescriptions post-discharge continues to pose challenges for patients with opioid use disorder discharged from the emergency department, promoting their return to opioid use.
  Medscape Medical News, January 01, 2024
  3
• How Accurately Can ChatGPT Answer Cardiac Arrest Queries? ChatGPT's ability to respond to cardiac arrest inquiries by survivors, their relatives, and lay rescuers was investigated, revealing its accuracy and limitations.
  Medscape Medical News, December 29, 2023
• High-Sensitivity Troponin Offers AMI Diagnostic Edge The study showed that a new HEART pathway involving high-sensitivity troponin outperformed conventional troponin in ED chest pain evaluations, detecting acute myocardial infarction more effectively.
  Medscape Medical News, December 29, 2023
  2
• Building a Toolkit for the Treatment of Acute Migraine Selecting a treatment plan to deal with acute migraine attacks is like putting together a toolkit of possible therapies which can be individualized for each patient, one expert said.
  Medscape Medical News, December 28, 2023
  11
• Elafibranor Appears Effective, Safe for PBC Treatment with elafibranor showed significantly greater improvements in relevant biochemical indicators of cholestasis than the placebo.
  Medscape Medical News, December 28, 2023
• New Trials in Breast Cancer: Could Your Patient Benefit? Patients with breast cancer might be eligible to enroll in one of these clinical trials.
  Medscape Medical News, December 27, 2023
• 'Real-time Experiment': Compounded GLP-1s on Coupon Site Purveyors on coupon sites like Groupon are marketing weight loss programs that include compounded semaglutide and tirzepatide.
  Medscape Medical News, December 26, 2023
  6
• Opioid Agonist Therapy Underused, Data Suggest The low rates of opioid agonist therapy administration over time suggest that additional efforts are needed to promote this intervention in acute care settings, according to the researchers.
  Medscape Medical News, December 22, 2023
  5
• Monoclonal Antibodies: A New Treatment for Long COVID? A small study generated impressive results.
  Medscape Medical News, December 22, 2023
  28
• 'Hidden Hearing Loss' May Cause Tinnitus: Study Some people who have tinnitus are still able to perform well on standard hearing tests, according to researchers at the Massachusetts Eye and Ear Infirmary.
  WebMD Health News, December 04, 2023
  22
• ASH 2023 ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
  MDedge News, December 04, 2023
• How Will the Supreme Court Reshape US Opioid Epidemic Relief? The Supreme Court is set on Monday to hear arguments over the legality of a roughly $6 billion bankruptcy settlement involving Purdue Pharma.
  Reuters Health Information, December 03, 2023
• Social Contagion Influences Buprenorphine Initiation for OUD Despite being safe and effective, emergency department initiation of buprenorphine for opioid use disorder remains an underutilized practice, necessitating the evaluation of factors affecting its adoption.
  Medscape Medical News, December 04, 2023
  1
• Procedures May Ease Postmenopausal Pain Better Than Drugs Postmenopausal women report more significant improvements in chronic pain after procedural interventions when compared with their younger counterparts, despite being notably less likely to use muscle relaxants, TCAs, and benzodiazepines.
  Medscape Medical News, December 01, 2023
• Eight Wealth Tips Just for Doctors These money experts are doctors themselves and understand the unique financial needs of physicians. Here's what they suggest.
  Medscape Medical News, December 01, 2023
  8
• What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
  Medscape Medical News, December 01, 2023
  34
• FTC Chief Gears Up for a Showdown With Private Equity Lina Khan, chair of the FTC, says a recent lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.
  KFF Health News, December 01, 2023
  4
• Drugs to Prevent vs Those to Treat Migraine Might Not Share Targets 'I think this explains some of the frustration at trigger modulation. I think we are often trying to modulate a process that has already got started,' said Dr Peter Goadsby of King's College London.
  MDedge News, November 29, 2023
  4
• AANEM 2023 Novel Myasthenia Gravis Therapies Bring Opportunities New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.
  MDedge News, November 27, 2023
• Alert FDA Approves Nirogacestat for Desmoid Tumors This is the first drug approved to treat desmoid tumors.
  Medscape Medical News, November 27, 2023
• Metoclopramide Nasal Spray Eases Gastroparesis in Women A nasal spray formulation of metoclopramide was well tolerated and reduced symptoms of diabetic gastroparesis in women with moderate to severe baseline symptoms in a phase 3 study
  Medscape Medical News, November 27, 2023
• Chest Pain With Long COVID Common but Undertreated A Mayo Clinic study found nearly 90% of patients with long COVID experience chest pain, but treatment for this condition is not yet standardized.
  Medscape Medical News, November 22, 2023
  4
• New Guidance on the Management of Stimulant Use Disorder Stimulant use disorder is common and deadly, but there’s been scant guidance to inform clinical management. Two professional societies have just released a comprehensive guideline.
  Medscape Medical News, November 22, 2023
  4
• Chronic Pain in the US: New Data In 2020, 25% of US adults with chronic pain managed their symptoms with medication alone versus nonpharmalogic treatments such as physical, occupational, or cognitive behavioral therapies.
  Medscape Medical News, November 22, 2023
  26
• WCN 2023 A Role for Neurologists in Diabetic Peripheral Neuropathy The rise in diabetic neuropathy over the last few decades has paralleled the obesity and related diabetes pandemics, one expert says, and neurologists have a role to play in controlling it.
  Medscape Medical News, November 21, 2023
  8
• FDA Warns Against Using Cardinal's Syringes The FDA on Monday warned healthcare providers and facilities not to use Cardinal Health's Monoject syringes with patient-controlled pain management pumps and syringe pumps.
  Reuters Health Information, November 20, 2023
• Choosing the Right Approach to Cancer and Menopause Symptoms Hormone replacement therapy may be considered to lessen these symptoms, but only in certain conditions, said a gynecologist.
  Medscape Medical News, November 21, 2023
• ACR 2023 IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.
  MDedge News, November 20, 2023
• Rite Aid Sues US Justice Dept to Stop Opioid Lawsuit Rite Aid sued the US Department of Justice, seeking to block a lawsuit alleging that they ignored red flags and illegally filled hundreds of thousands of prescriptions for addictive opioid medication.
  Reuters Health Information, November 16, 2023